Cytokine mediated endothelial activation during and after normothermic cardiopulmonary bypass: Heparin-bonded versus non heparin-bonded circuits

ASAIO Journal

Volumn 46, Issue 6, 2000, Pages 740-743

  Misawa, Yoshio ^a   Kawahito, Koji ^a   Konishi, Hiroaki ^a   Fuse, Katsuo ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOASSAY; BLOOD; CARDIOVASCULAR SURGERY; CARDIOVASCULAR SYSTEM; ENZYMES; OXYGENATORS; PATIENT TREATMENT; STATISTICAL METHODS;

CHEMILUMINESCENT ENZYME IMMUNOASSAY METHOD; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; GRANULOCYTE ELASTASE; HEPARIN; INTERLEUKIN; NORMOTHERMIC CARDIOPULMONARY BYPASS; PROINFLAMMATORY MEDIATORS; THROMBOMODULIN;

CELLS;

ELASTASE; HEPARIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; INTERLEUKIN 8; THROMBOMODULIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOTHELIUM CELL; FEMALE; HEPARINIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOSTIMULATION; ISCHEMIC HEART DISEASE; MALE; OXYGENATOR;

EID: 0034326921     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002480-200011000-00016     Document Type: Article

References (25)

1. Inflammatory response to cardiopulmonary bypass using two different types of heparin-coated extracorporeal circuits
2. Heparin coating of extracorporeal circuits inhibits contact activation during cardiac operations
3. Release of proinflammatory cytokines during pediatric cardiopulmonary bypass: Heparin-bonded versus nonbonded oxygenators
4. Heparin-coated circuits reduce the inflammatory response to cardiopulmonary bypass
5. Assessment of the myocardial protective effect of antegrade warm blood cardioplegia by measuring the release of biochemical markers
6. Production of soluble ICAM-1 from human endothelial cells induced by IL-1β and TNF
7. Inflammatory response to cardiopulmonary bypass
8. Complement activation, cytokines, and adhesion molecules in children undergoing cardiac surgery with or without cardiopulmonary bypass
9. Cytokine and compliment levels in patients undergoing cardiopulmonary by-pass
10. Heparin-coated cardiopulmonary bypass equipment: II. Mechanisms for reduced compliment activation in vivo
11. Heparin-coated cardiopulmonary bypass equipment: I. Biocompatibility markers and development of complications in a high-risk population
12. Heparin-bonded circuits decrease myocardial ischemic damage: An experimental study
13. Heparin-coated circuits for high-risk patients: A multicenter, prospective, randomized trial
14. Reduced compliment activation and improved postoperative performance after cardiopulmonary bypass with heparin-coated circuits
15. Microvascular endothelial activation in the skeletal muscles of patients with multiple organ failure
16. Effects of cardiopulmonary bypass on leukocyte and endothelial adhesion molecules
17. Expression of soluble endothelial adhesion molecules in clinical cardiopulmonary bypass
18. Soluble adhesion molecules in reperfusion during coronary bypass grafting
19. Soluble adhesion molecules in infants and children undergoing cardiopulmonary bypass
20. Circulating adhesion molecules in pediatric cardiac surgery
21. Endothelial-related coagulation in pediatric surgery
22. Thrombomodulin and angiotensin-converting enzyme activity during pediatric open heart operations
23. Normothermic versus hypothermic cardiopulmonary bypass: Do changes in coagulation differ?
24. Endothelial-related coagulation in cardiac surgery
25. Changes in leucocyte counts and soluble intercellular adhesion molecule-1 and E-selectin during cardiopulmonary bypass in children